Inhibikase Therapeutics IKT Q1 2026 Earnings Narrowing Losses as Pipeline Progress Takes Center Stage NCMI Q1 2026 Earnings EPS Misses Estimates by 18 Stock Declines Voyager Therapeutics Q1 2026 Earnings EPS Beats Estimates as Stock Rises Amid Pipeline Progress Fuel Tech Inc FTEK Q1 2026 Earnings EPS Misses Estimates Revenue Unreported Stock Up 207 Kestrel Group Ltd Q3 2024 Earnings Reported Loss of 016 Per Share as Stock Edges Higher NRXS Q1 2026 Earnings EPS Beats Estimates Despite Revenue Absence